НовостиBenzingaAgomab Therapeutics Experimental Drug Delivers Sustained Disease Control in Long-Term Crohn's Disease Trial Agomab Therapeutics Experimental Drug Delivers Sustained Disease Control in Long-Term Crohn's Disease Trial Benzinga 2026.10.01 18:31 (GMT+0) Открыть на Benzinga Другие новости